Cargando…
Ruthenium Complexes as Promising Candidates against Lung Cancer
Lung cancer is one of the most common malignancies with the highest mortality rate and the second-highest incidence rate after breast cancer, posing a serious threat to human health. The accidental discovery of the antitumor properties of cisplatin in the early 1960s aroused a growing interest in me...
Autores principales: | Sun, Qi, Li, Yingsi, Shi, Hongdong, Wang, Yi, Zhang, Jitian, Zhang, Qianling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348655/ https://www.ncbi.nlm.nih.gov/pubmed/34361543 http://dx.doi.org/10.3390/molecules26154389 |
Ejemplares similares
-
Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy
por: Zhang, Cheng, et al.
Publicado: (2022) -
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015) -
Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review
por: Munteanu, Alexandra-Cristina, et al.
Publicado: (2021) -
Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment
por: Li, Xiang, et al.
Publicado: (2021) -
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
por: Golbaghi, Golara, et al.
Publicado: (2020)